REAL

Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 is based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux

Bormio Nunes, Julia H. and Hager, Sonja and Mathuber, Marlene and Pósa, Vivien and Roller, Alexander and Enyedy, Éva A. (2020) Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 is based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux. JOURNAL OF MEDICINAL CHEMISTRY, 63. pp. 13719-13732. ISSN 0022-2623 (print); 1520-4804 (online)

[img]
Preview
Text
acs.jmedchem.0c01277.pdf
Available under License Creative Commons Attribution.

Download (5MB) | Preview
Item Type: Article
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat > RC0254 Neoplasms. Tumors. Oncology (including Cancer) / daganatok, tumorok, onkológia
R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan
SWORD Depositor: MTMT SWORD
Depositing User: MTMT SWORD
Date Deposited: 08 Dec 2020 16:02
Last Modified: 08 Dec 2020 16:02
URI: http://real.mtak.hu/id/eprint/118023

Actions (login required)

Edit Item Edit Item